These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 11136884)
1. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Reinhold-Keller E; Zeidler A; Gutfleisch J; Peter HH; Raspe HH; Gross WL Rheumatology (Oxford); 2000 Dec; 39(12):1396-402. PubMed ID: 11136884 [TBL] [Abstract][Full Text] [Related]
2. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Herlyn K; Buckert F; Gross WL; Reinhold-Keller E Rheumatology (Oxford); 2014 May; 53(5):882-9. PubMed ID: 24425780 [TBL] [Abstract][Full Text] [Related]
3. No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register. Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gutfleisch J; Peter HH; Raspe HH; Gross WL Rheumatology (Oxford); 2002 May; 41(5):540-9. PubMed ID: 12011378 [TBL] [Abstract][Full Text] [Related]
4. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies. Romero-Gómez C; Aguilar-García JA; García-de-Lucas MD; Cotos-Canca R; Olalla-Sierra J; García-Alegría JJ; Hernández-Rodríguez J Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-11-8. PubMed ID: 25437862 [TBL] [Abstract][Full Text] [Related]
5. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553 [TBL] [Abstract][Full Text] [Related]
6. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795 [TBL] [Abstract][Full Text] [Related]
7. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period. Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746 [TBL] [Abstract][Full Text] [Related]
8. Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain. Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J J Rheumatol; 2003 Jul; 30(7):1548-51. PubMed ID: 12858456 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. González-Gay MA; Garcia-Porrua C; Rivas MJ; Rodriguez-Ledo P; Llorca J Ann Rheum Dis; 2001 Apr; 60(4):367-71. PubMed ID: 11247867 [TBL] [Abstract][Full Text] [Related]
10. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015. Crowson CS; Matteson EL Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169 [TBL] [Abstract][Full Text] [Related]
11. Stable incidence of systemic vasculitides in schleswig-holstein, Germany. Herlyn K; Hellmich B; Gross WL; Reinhold-Keller E Dtsch Arztebl Int; 2008 May; 105(19):355-61. PubMed ID: 19629246 [TBL] [Abstract][Full Text] [Related]
12. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study. Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164 [TBL] [Abstract][Full Text] [Related]
13. Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway. Andersen JB; Myklebust G; Haugeberg G; Pripp AH; Diamantopoulos AP Arthritis Care Res (Hoboken); 2021 Mar; 73(3):409-414. PubMed ID: 31909871 [TBL] [Abstract][Full Text] [Related]
14. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study. Muratore F; Boiardi L; Mancuso P; Restuccia G; Galli E; Marvisi C; Macchioni P; Rossi PG; Salvarani C Semin Arthritis Rheum; 2021 Aug; 51(4):786-792. PubMed ID: 34148007 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Watts RA; Lane SE; Bentham G; Scott DG Arthritis Rheum; 2000 Feb; 43(2):414-9. PubMed ID: 10693883 [TBL] [Abstract][Full Text] [Related]
16. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Sørensen SF; Slot O; Tvede N; Petersen J Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866 [TBL] [Abstract][Full Text] [Related]
17. Incidence and prevalence of giant cell arteritis in Ontario, Canada. Barra L; Pope JE; Pequeno P; Saxena FE; Bell M; Haaland D; Widdifield J Rheumatology (Oxford); 2020 Nov; 59(11):3250-3258. PubMed ID: 32249899 [TBL] [Abstract][Full Text] [Related]
18. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study. Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140 [TBL] [Abstract][Full Text] [Related]